Skip to main content
SpringerLink
Log in

Palliative radiation therapy for pulmonary metastases from hepatocellular carcinoma

  • Research Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Although the lung is the most common site of extrahepatic metastases from hepatocellular carcinoma (HCC), the optimal treatment for such metastases has’nt been established. External beam radiotherapy (EBRT) is becoming a useful local control therapy for lung cancer. To evaluated the efficacy of EBRT treatment for such metastases, we retrospectively studied 13 patients (11 men and 2 women; mean age, 52.6 years) with symptomatic pulmonary metastases from HCC who had been treated with EBRT in our institution. The palliative radiation dose delivered to the lung lesions ranged from 47 to 60 Gy (median 50) in conventional fractions, while the intrahepatic lesions were treated with surgery or transarterial chemoembolization, and/or EBRT. Follow-up period from radiotherapy ranged from 3.7 to 49.1 months (median, 16.7). Among the 13 patients, 23 out of a total of 31 pulmonary metastatic lesions received EBRT. In 12/13(92.3%) patients, significant symptoms were completely or partially relieved. An objective response was observed in 10/13(76.9%) of the subjects by computed tomography imaging. The median progression-free survival for all patients was 13.4 months. The 2-year survival rate from pulmonary metastasis was 70.7%. Adverse effects were mild and consisted of bone marrow suppression in three patients and pleural effusion in one patient (all CTCAE Grade II). In conclusion, EBRT with ≤60 Gy appears to be a good palliative therapy with reasonable safety for patients with pulmonary metastases from HCC. However, large-scale randomized clinical trials will be necessary to confirm the therapeutic role of this method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

HCC:

Hepatocellular carcinoma

EBRT:

External beam radiotherapy

CT:

Computed tomography

BACE:

Bronchial arterial chemoembolization

AFP:

α-Fetoprotein

CEA:

Carcinoembryonic antigen

CA19-9:

Carbohydrate antigen 19-9

PmFI:

Pulmonary metastases-free interval

TACE:

Transarterial chemoembolization

3D-CRT:

Three-dimensional conformal radiation therapy

GTV:

Gross tumor volume

CTV:

Clinical target volume

PTV:

Planning target volume

DVH:

Dose–volume histogram

OARs:

Organs at risk

BED:

Biologic effective dose

RECIST:

Response evaluation criteria in solid tumors

CR:

Complete response

PR:

Partial response

SD:

Stable disease

PD:

Progression of disease

CTCAE:

Common terminology criteria for adverse events

PFS:

Progression-free survival time

CI:

Confidence interval

WBC:

Whiter blood cell counts

References

  1. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, Nakanuma Y, Okita K, Omata M, Takayasu K, Yamaoka Y (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:796–802. doi:10.1002/cncr.20426

    Article  PubMed  Google Scholar 

  2. Yoon YS, Kim HK, Kim J, Choi YS, Shim YM, Paik SW, Kim K (2010) Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 17:2795–2801. doi:10.1245/s10434-010-1073-5

    Article  PubMed  Google Scholar 

  3. Chen F, Sato K, Fujinaga T, Sonobe M, Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Date H (2008) Pulmonary resection for metastases from hepatocellular carcinoma. World J Surg 32:2213–2217. doi:10.1007/s00268-008-9684-8

    Article  PubMed  Google Scholar 

  4. Tomimaru Y, Sasaki Y, Yamada T, Eguchi H, Takami K, Ohigashi H, Higashiyama M, Ishikawa O, Kodama K, Imaoka S (2006) The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg 192:46–51. doi:10.1016/j.amjsurg

    Article  PubMed  Google Scholar 

  5. Hiraki T, Gobara H, Takemoto M, Mimura H, Mukai T, Himei K, Hase S, Iguchi T, Fujiwara H, Yagi T, Tanaka N, Kanazawa S (2006) Percutaneous radiofrequency ablation combined with previous bronchial arterial chemoembolization and followed by radiation therapy for pulmonary metastasis from hepatocellular carcinoma. J Vasc Interv Radiol 17:1189–1193. doi:10.1097/01.RVI.0000228370.09886.66

    Article  PubMed  Google Scholar 

  6. Li C, Zhang F, Zhang W, Zhang L, Huang Z, Wu P (2010) Feasibility of (125)I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma. J Cancer Res Clin Oncol 136:1633–1640. doi:10.1007/s00432-010-0821-z

    Article  PubMed  CAS  Google Scholar 

  7. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216. doi:10.1093/jnci/92.3.205

  8. Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0. (2006) DCTDN, NIH, NHHS. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed August 9, 2006

  9. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, Takayasu K, Nakanuma Y, Makuuchi M, Matsuyama Y, Monden M, Kudo M (2007) Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 37:676–691. doi:10.1111/j.1872-034X.2007.00119.x

    Article  PubMed  Google Scholar 

  10. Chua TC, Morris DL (2011) Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma. Surg Oncol. doi:10.1016/j.suronc.2011.01.005

  11. Zhang SM, Zeng ZC, Tang ZY, Sun J, Cheng JM, Liu R, Wang P, Zhang BH (2008) Prognostic analysis of pulmonary metastases from hepatocellular carcinoma. Hepatol Int 2:237–243. doi:10.1007/s12072-008-9052-7

    Article  PubMed  Google Scholar 

  12. The International Registry of Lung Metastases, Writing Committee, Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, Johnston M, McCormack P, Pass H, Putnam JB Jr (1997) Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113:37–49

    Google Scholar 

  13. He J, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, Wang JH, Sun J, Chen B, Yang P, Pan BS (2009) Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer 115:2710–2720. doi:10.1002/cncr.24300

    Article  PubMed  Google Scholar 

  14. Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Zhang JY, Yu Y, Cheng JM, Wang XL, Guo W (2005) Radiation therapy for adrenal gland metastases from hepatocellular carcinoma. Jpn J Clin Oncol 35:61–67. doi:10.1093/jjco/hyi020

    Article  PubMed  Google Scholar 

  15. Cheng JC, Chou CH, Kuo ML, Hsieh CY (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25:7009–7018. doi:10.1038/sj.onc.1209706

    Article  PubMed  CAS  Google Scholar 

  16. Jia JB, Wang WQ, Sun HC, Liu L, Zhu XD, Kong LQ, Chai ZT, Zhang W, Zhang JB, Xu HX, Zeng ZC, Wu WZ, Wang L, Tang ZY (2010) A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Invest New Drugs 29:861–872. doi:10.1007/s10637-010-9435-1

    Article  PubMed  Google Scholar 

  17. Tsuchiya A, Imai M, Kamimura H, Togashi T, Watanabe K, Seki K, Ishikawa T, Ohta H, Yoshida T, Kamimura T (2009) Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil. World J Gastroenterol 15:1779–1781. doi:10.3748/wjg.15.1779

    Article  PubMed  Google Scholar 

  18. Girard N, Mornex F (2011) Sorafenib and radiotherapy association for hepatocellular carcinoma. Cancer Radiother 15:77–80. doi:10.1016/j.canrad.2010.11.012

    Article  PubMed  CAS  Google Scholar 

  19. Jang JW, Kay CS, You CR, Kim CW, Bae SH, Choi JY, Yoon SK, Han CW, Jung HS, Choi IB (2009) Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys 74:412–418. doi:10.1016/j.ijrobp.2008.08.034

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Funding

None.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai, 200032, China

    Wei Jiang, Zhao-Chong Zeng & Jian-Ying Zhang

  2. Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China

    Jia Fan & Jian Zhou

  3. Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China

    Meng-Su Zeng

Authors
  1. Wei Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhao-Chong Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian-Ying Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jia Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Meng-Su Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jian Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhao-Chong Zeng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, W., Zeng, ZC., Zhang, JY. et al. Palliative radiation therapy for pulmonary metastases from hepatocellular carcinoma. Clin Exp Metastasis 29, 197–205 (2012). https://doi.org/10.1007/s10585-011-9442-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-011-9442-4

Keywords

Search

Navigation